| Wendy Ann Hoffmeyer, PHARMD | |
|
3330 E Calumet St, Appleton, WI 54915-4127 | |
| (920) 733-3016 | |
| (920) 733-3218 |
| Full Name | Wendy Ann Hoffmeyer |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 3330 E Calumet St, Appleton, Wisconsin |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1407132491 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 14253-040 (Wisconsin) | Primary |
| 183500000X | Pharmacist | 5302033348 (Michigan) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Wendy Ann Hoffmeyer, PHARMD N7834 Edgewater Ct, Sherwood, WI 54169-9662 Ph: (920) 989-1398 | Wendy Ann Hoffmeyer, PHARMD 3330 E Calumet St, Appleton, WI 54915-4127 Ph: (920) 733-3016 |
News Archive
Survival rates for elderly patients who received stereotactic body radiation therapy (SBRT) for early stage non-small cell lung cancer (NSCLC) rose from roughly 40 to 60 percent over the past decade, concurrent with the increasing adoption of SBRT, according to research presented today at the 58th Annual Meeting of the American Society for Radiation Oncology.
Small regulatory RNA molecules are vital for salmonella and other bacteria potentially harmful to humans: This RNA type controls gene activity and allows bacteria to quickly adjust to changing conditions of living and stress as are typical during an infection, for example, when entering the blood stream or inside human cells.
Scientists at the University of California, San Diego School of Medicine have received a major 7-year, $18 million grant to begin translating emerging discoveries in the field of glycosciences into new discoveries and therapies related to heart, lung and blood diseases.
Working with human neurons and fruit flies, researchers at Johns Hopkins have identified and then shut down a biological process that appears to trigger a particular form of Parkinson's disease present in a large number of patients. A report on the study, in the April 10 issue of the journal Cell, could lead to new treatments for this disorder.
CEVEC Pharmaceuticals, the German developer of a novel human expression system derived from amniocytes, announced today the signing of an exclusive license option agreement with Pevion Biotech, the Swiss vaccine company. The agreement enables Pevion Biotech to exclusively use CEVEC's transient CAP-T™ cell expression technology to manufacture and commercialize a protein antigen for vaccination against a widespread human infectious disease.
› Verified 7 days ago
Jennifer Marie Fleege, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1800 S Kensington Dr, Appleton, WI 54915 Phone: 920-749-9775 | |
Dr. Nicholas Laricchia, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1800 S Kensington Dr, Appleton, WI 54915 Phone: 920-749-9775 | |
Christy Vogel, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 955 N Mutual Way, Appleton, WI 54913 Phone: 920-954-6400 | |
Karla Knobbe, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 10 Tri Park Way, Appleton, WI 54914 Phone: 920-831-0070 | |
Dr. Tou Xiong Thao, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1818 N Meade Street, Appleton, WI 54911 Phone: 920-454-3200 | |
Ms. Elizabeth M Simon-wochinski, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: N162 Eisenhower Dr, Appleton, WI 54915 Phone: 920-731-4830 | |
Drazen Savic, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2803 N Meade St, Appleton, WI 54911 Phone: 920-830-6985 |